OncoTherapy Network offers the latest oncology information for clinicians on targeted therapies and immunotherapies in the areas of breast, brain, GI, GU, head and neck, hematologic, lung, and skin.
http://www.oncotherapynetwork.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
0.4 seconds
16x16
UBM Medica
UBM Medica
535 Con●●●●●●● Avenue
No●●lk , CT, 06854
US
View this contact
DNS Admin
DNS Admin
535 Con●●●●●●● Avenue
No●●lk , CT, 06854
US
View this contact
DNS Admin
DNS Admin
535 Con●●●●●●● Avenue
No●●lk , CT, 06854
US
View this contact
BUY YOUR DOMAIN
10
YEARS
3
MONTHS
5
DAYS
CSC CORPORATE DOMAINS, INC.
WHOIS : whois.corporatedomains.com
REFERRED : http://www.cscglobal.com
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
371
SITE IP
104.24.96.206
LOAD TIME
0.359 sec
SCORE
6.2
Oncotherapy Network | oncotherapynetwork.com Reviews
https://oncotherapynetwork.com
OncoTherapy Network offers the latest oncology information for clinicians on targeted therapies and immunotherapies in the areas of breast, brain, GI, GU, head and neck, hematologic, lung, and skin.
oncotherapynetwork.com
Skin Cancer / Melanoma Targets | OncoTherapy Network
http://www.oncotherapynetwork.com/skin-cancer-melanoma-targets
Skip to main content. Skin Cancer / Melanoma Targets. FDA Approves Opdivo-Yervoy Combo for Unresectable or Metastatic Melanoma. The FDA has approved Opdivo in combination with Yervoy for treating unresectable or metastatic melanoma. Skin Cancer / Melanoma Targets. Skin Cancer / Melanoma Targets. Avelumab Approved for Treating Metastatic Merkel Cell Carcinoma. March 27, 2017. Skin Cancer / Melanoma Targets. Nanoparticle-Based Treatment in Melanoma. March 22, 2017. Skin Cancer / Melanoma Targets. Chemical ...
Podcasts | OncoTherapy Network
http://www.oncotherapynetwork.com/podcasts
Skip to main content. Skin Cancer / Melanoma Targets. First Human Study Taking Place With Fatty Acid Synthase Inhibitor. Gerald S. Falchook, MD. April 07, 2017. By Gerald S. Falchook, MD. We spoke with Dr. Gerald Falchook about the first human study of a first-in-class molecule, fatty acid synthase inhibitor known as TVB-2640 for advanced solid tumors. Lung Cancer Survival Rates Improving With Nivolumab. Julie R. Brahmer, MD. April 04, 2017. By Julie R. Brahmer, MD. G Larry Maxwell, MD. March 17, 2017.
ASCO 2015 | OncoTherapy Network
http://www.oncotherapynetwork.com/asco-2015
Skip to main content. Skin Cancer / Melanoma Targets. ASCO 2015: Sarcoma Poster Presentations and Discussions. Juneko Grilley-Olson, MD. June 29, 2015. Bone and Soft Tissue Cancer Targets. By Juneko Grilley-Olson, MD. Sarcomas are a heterogeneous and motley collection of cancers, which struggle with an identity crisis on many levels. The trials often lump vastly different subgroups, and are often unable to collect sufficient numbers of any one disease subtype to complete a unique cohort. June 25, 2015.
Slide Show: Trends in Targeted Therapies and Immunotherapies | OncoTherapy Network
http://www.oncotherapynetwork.com/lung-cancer-targets/slide-show-trends-targeted-therapies-and-immunotherapies
Skip to main content. Connect to other sites within the UBM Medica Network. Slide Show: Trends in Targeted Therapies and Immunotherapies. Slide Show: Trends in Targeted Therapies and Immunotherapies. July 21, 2015. Skin Cancer / Melanoma Targets. By OncoTherapy Network Staff. IMS Institute for Healthcare Informatics. (2015). Developments in Cancer Treatments, Market Dynamics, Patient Access and Value: Global Oncology Trend Report 2015. You can download them to Word using copy. I downloaded the entire...
Lung Cancer Targets | OncoTherapy Network
http://www.oncotherapynetwork.com/lung-cancer-targets
Skip to main content. Connect to other sites within the UBM Medica Network. Telomere Length Genes Predict Lung Adenocarcinoma Risk. Genes associated with longer telomere length may increase the risk of lung cancer. Image koya979/ Shutterstock.com. Image koya979 / Shutterstock.com. Skin Cancer / Melanoma Targets. Lung Cancer Patients With EGFR Mutations Respond Well to TKI Therapy. August 24, 2016. By Lauren Evoy Davis. Might Computers Predict Patient Survival Better Than Pathologists? August 22, 2016.
TOTAL PAGES IN THIS WEBSITE
20
DSM-5 | Psychiatric Times
http://www.psychiatrictimes.com/dsm-5-0
Skip to main content. Connect to other sites within the UBM Medica Network. Get the latest information on the Diagnostic and Statistical Manual of Mental Disorders. August 22, 2016. And Yitzchak M. Binik, PhD. The inability or difficulty to experience vaginal penetration is most similar to which DSM-5 disorder? Find out in this quiz. Update on Diagnostic Issues for Borderline Personality Disorder. Peter Fonagy, OBE, FMedSci, FBA, PhD. Chloe Campbell, PhD. Anthony W. Bateman, MA, FRCPsych. July 19, 2016.
Suicide | Psychiatric Times
http://www.psychiatrictimes.com/suicide
Skip to main content. Connect to other sites within the UBM Medica Network. What Depression Does to Our Minds When It Attacks. Depression is overwhelming and overpowering, and it crushes its prey." By a pediatrician who tells of her 40-year battle with severe depression. Introduction: A Focus on Differential Diagnoses, Comorbidity, and Suicide Risk. Keming Gao, MD, PhD. August 31, 2016. By Keming Gao, MD, PhD. Lessons Learned From the International Society for Bipolar Disorders Task Force on Suicide.
Breast Imaging | Diagnostic Imaging
http://www.diagnosticimaging.com/breast-imaging
Skip to main content. Connect to other sites within the UBM Medica Network. Analyzing the Options of Breast Imaging Technology. With controversy lingering around mammography, advances in breast imaging may provide safer and more effective options. Molecular Breast Imaging Supplemental Screening for Dense Breasts. August 10, 2016. By Diagnostic Imaging Staff. MBI assessed as supplementary screening tool for women with dense breasts. Prior Mammogram Access Important as Screening Protocols in Flux. UPDATED&...
Image IQ | Diagnostic Imaging
http://www.diagnosticimaging.com/image-iq
Skip to main content. Connect to other sites within the UBM Medica Network. Image IQ: 65-year old female, Altered Mental Status, SIRS. May 26, 2016. By Alex Heaton, MD. And Erini Makariou, MD. 65-year-old female with sickle cell anemia and ESRD status postrenal transplant presenting with AMS and SIRS. Image IQ: 65-year old Male, Left Sensorineural Hearing Loss. April 14, 2016. By Akemi D. Miller, MD. And Erini V. Makariou, MD. 65-year-old male presents with left sensorineural hearing loss. March 31, 2016.
Patients Versus Therapists: Legal Actions Over Recovered Memory Therapy | Psychiatric Times
http://www.psychiatrictimes.com/dissociative-identity/content/article/10168/49266
Skip to main content. Connect to other sites within the UBM Medica Network. Patients Versus Therapists: Legal Actions Over Recovered Memory Therapy. Patients Versus Therapists: Legal Actions Over Recovered Memory Therapy. November 01, 1999. By Harold I. Lief, MD. Between 1923 and 1993 the courts relied on the. Test when accepting scientific evidence. Evidence was accepted in the courtroom if there was general acceptance in the scientific community. James Frye v US, 293 F. 1013 [1923]). In 1993, with.
Obesity | Physicians Practice
http://uat.physicianspractice.com/obesity
Skip to main content. Medical Billing and Collections. Connect to other sites within the UBM Medica Network. Medical Billing and Collections. Great American Physician Survey. Medical Billing and Collections. Patient Flow Wait Times. Less Severe Diabetes Has Better Remission With Surgery. Mark L. Fuerst. November 19, 2014. By Mark L. Fuerst. Bariatric Surgery Cuts Diabetes Drug Use and Costs. Mark L. Fuerst. November 18, 2014. By Mark L. Fuerst. FDA Approves New Anti-Obesity Drug. September 23, 2014.
Physician Compensation | Physicians Practice
http://uat.physicianspractice.com/physician-compensation
Skip to main content. Medical Billing and Collections. Connect to other sites within the UBM Medica Network. Medical Billing and Collections. Our 2013 Physician Compensation Survey highlights financial challenges facing today's physicians and medical practices. But with obstacles also come opportunities. Check out the full data from our 2013 survey. Based on replies from close to 1,500 physicians. Great American Physician Survey. Medical Billing and Collections. Patient Flow Wait Times. December 23, 2013.
Modalities | Diagnostic Imaging
http://www.diagnosticimaging.com/modalities
Skip to main content. Connect to other sites within the UBM Medica Network. Presenting Diagnostic Imaging Executive. The newest resource for health care executives. Five Ways Healthcare CIOs Break Down Departmental Barriers to Bring a Single View of the Patient Care Record to Life. Facing the Challenges Ahead in Diagnostic Imaging. Michiana Hematology Oncology Success Story. Ultralow-Dose Chest Computed Tomography for Pulmonary. 5 Compelling Reasons to Reevaluate Your Test Results Process.
Ultrasound | Diagnostic Imaging
http://www.diagnosticimaging.com/ultrasound
Skip to main content. Connect to other sites within the UBM Medica Network. Should radiologists be threatened by the adoption of point-of-care ultrasound? Lung Ultrasound, Siege Sonography. Jason Birnholz, MD. July 29, 2016. By Jason Birnholz, MD. The power and limitations of lung ultrasound. Many Shoulder MRIs Unnecessary. July 27, 2016. By Diagnostic Imaging Staff. Ultrasound, rather than MRI, is often appropriate imaging for shoulder injuries. Lower Limb Pain During Physical Activity. July 05, 2016.
Molecular Imaging | Diagnostic Imaging
http://www.diagnosticimaging.com/molecular-imaging
Skip to main content. Connect to other sites within the UBM Medica Network. These Imaging Tests Aren’t Always Necessary. PET/CT for cancer screening in healthy patients? Think twice on this and other nuclear medicine and molecular imaging tests, says the Society for Nuclear Medicine and Molecular Imaging's Choosing Wisely list. Brain Imaging Identifies Changes in NFL Players. May 09, 2016. By Diagnostic Imaging Staff. Imaging with SPECT can identify brain trauma among NFL players. April 21, 2016. CTA Sup...
TOTAL LINKS TO THIS WEBSITE
371
Oncotherapeutics
Full Service Contract Research Organization (CRO). Our Mission and Values. Site Recruitment and Activation. Quality Assurance and Compliance. Our Mission and Values. Site Recruitment and Activation. Quality Assurance and Compliance. Oncotherapeutics is a full service Contract Research Organization (CRO) with a unique focus in oncology. Our history of client satisfaction and success is the best testimony of our commitment to our clients. Oncotherapeutics presents at ASH 2014. A Phase 1/2 Study of Carfilzo...
Oncotherapeutics
Full Service Contract Research Organization (CRO). Oncotherapeutics offers a comprehensive service portfolio that supports preclinical studies and clinical trials from phase I to IV. We strive to provide high quality deliverables and our clients, from small start-up biotech (16-50 employees) to large biotechnology and pharmaceuticals (10,000 employees), enjoy the benefits of our proactive, specialized approach. MEDNET Solutions Welcomes Oncotherapeutics to the MEDNET Partner Program. Website Design by AI...
OncoTherapy Science, Inc.
がん特異的ペプチドワクチン S-588410 第 相臨床試験進捗 最終患者登録 に関するお知らせ. 当社連結子会社と Thermo Fisher Scientific との新規リキッドバイオプシープラットフォーム評価のための提携についてのお知らせ. オンコセラピー サイエンス OTS では、がん分子標的治療薬の開発に適した標的遺伝子を多数同定しています。 血液 組織などの検体中に存在しているT細胞のTCR遺伝子配列情報を、次世代シーケンサーを用いて網羅的に取得し詳細に解析する T細胞受容体 TCR 解析サービス。 私たちは、 より治療効果が高く、より副作用の少ないがん治療薬 治療法を、一日も早くがんに苦しむ患者さんに届けること、がんとの闘いに勝つこと を目指し、ジェノミックスを医療分野に先駆者としてもたらした中村祐輔教授とともに、研究 開発に取り組んでいます。
US OncoTherapy systems BioMedicine Group
Oncotherapy Network
We've noticed that you're using an ad blocker. Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker. How do I disable my ad blocker? How to disable your ad blocker for our site:. Adblock / Adblock Plus. Click on the AdBlock / AdBlock Plus icon on the top right of your browser. Click Don’t run on pages on this domain. OR Enabled on this site. Close this help box and click "It's off now". Dec 21, 2017.
SD-IORT > Home
How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is SD-IORT available? For the Healthcare Professional. Information on the system. Where is SD-IORT available? How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is SD-IORT available? For the Healthcare Professional. Information on the system. Where is SD-IORT available? You are here: Home.
Home Page
Focusing on scientific discovery and innovation in targeted therapy and immuno-oncology to save human lives:. Cancer is the second most common cause of death in the US, exceeded only by heart disease. One of every four deaths in the United States is due to cancer. The American Cancer Society estimates that in 2014, about 1,665,540 Americans were diagnosed with invasive cancer, and 585,720 Americans died of this disease. The company currently has three preclinical programs:. Preclinical studies of these d...
Oncotherex | Cancers du sein et de l'ovaire
Cancers du sein et de l'ovaire. Cancers du sein et de l'ovaire. Oncotherex est spécialisée dans la mise en culture de tumeurs du sein et de l'ovaire permettant de tester l'efficacité thérapeutique de molécules innovantes. En savoir plus sur Oncotherex. Vous êtes une start-up, un laboratoire académique ou une entreprise pharmaceutique et vous souhaitez tester des molécules innovantes, venez vite découvrir nos offres. Oncotherex propose de nombreux tests sur ses tumeurs du sein et de l'ovaire. Bienvenue su...
OncoTherics News
Latest news and events from Oncotherics. Wednesday, 17 December 2014. OncoTherics signs collaboration agreement with University of Cambridge. OncoTherics has signed a collaboration agreement with the University of Cambridge to progress a series of novel preclinical investigations using OCT1002 in Pancreatic Tumour models. The investigations will augment OncoTherics formal preclinical studies, providing useful additional information about OCT1002 in Pancreatic Cancer. Wednesday, 16 July 2014. Weiss Medall...
SOCIAL ENGAGEMENT